Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in ...

In Part 6 of the Life Sciences Industry Report, we’ve collated key thought leadership from 2024 that looks at ways in which ...

According to Politico, Trump will issue an executive order in the next few days to pursue the use of a so-called 'most ...

Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

Robert F Kennedy Jr has launched a project to trawl federal databases to try to identify why there has been an increase in diagnoses of autism, but there are deep concerns about the project's ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

The NEJM has fired back a response to the Department of Justice (DoJ) asserting its "commitment to evidence-based ...

The 'Choose Europe for Science' scheme was revealed by President of the European Commission Ursula Von Der Leyen during a ...

The data used to train the AI – including vaccination records, GP visits, hospital admissions, and A&E attendances – is being ...